| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 |
| Total Revenue |
-
|
-
|
| Cost of Revenue |
-
|
-
|
|
| Gross Profit |
-
|
-
|
|
| Operating Expenses |
| Research Development |
-
|
-
|
| Selling General and Administrative | 1,282 | 101 |
| Non Recurring |
-
|
-
|
| Others |
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
|
|
| Operating Income or Loss | (1,282) | (101) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 1,616 | 340 |
| Earnings Before Interest And Taxes | 334 | 240 |
| Interest Expense |
-
|
-
|
| Income Before Tax | 334 | 240 |
| Income Tax Expense | 100 | 95 |
| Minority Interest |
-
|
-
|
| |
| Net Income From Continuing Ops | 235 | 144 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
| Extraordinary Items |
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
| Other Items |
-
|
-
|
|
|
| Net Income | 235 | 144 |
| Preferred Stock And Other Adjustments |
-
|
-
|
|
| Net Income Applicable To Common Shares | $235 | $144 |
0.20% Nasdaq 
Income Statement
